FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315703349> ?p ?o ?g. }

• W4315703349 endingPage "e306" @default.
• W4315703349 startingPage "e306" @default.
• W4315703349 abstract "Objective: The role of angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in the pandemic context of coronavirus disease 2019 (COVID-19) continues to be debated. Patients with hypertension, diabetes mellitus, chronic renal failure, cerebro-cardiovascular disease, or chronic obstructive pulmonary disease (COPD), who often use ACEi/ARB, may affect risk of severe COVID-19. However, there are no data available on the association of ACEi/ARB use with COVID-19 severity in this population. Design and method: This study is an observational study of patients with a positive SARS-CoV-2 test and inpatient treatment at a healthcare facility, using the registry information of COVIREGI-JP. Our primary outcomes were consisting of in-hospital death, ventilator support, extracorporeal membrane oxygenation support, and ICU admission. Out of the 6,055 patients, 1,921 patients with preexisting hypertension, diabetes mellitus, chronic renal failure, cerebro-cardiovascular disease, or COPD were enrolled. We also evaluated 1,097 patients with hypertension. Results: Factors associated with an increased risk of the primary outcomes were aging, male sex, COPD, severe renal impairment, and diabetes mellitus. No correlations were observed with ACEi/ARB, cerebro-cardiovascular diseases, or hypertension. Associated factors in male patients were aging, renal impairment, hypertension, and diabetes. In female patients, factors associated with an increased risk were aging, ACEi/ARB, renal impairment, and diabetes, whereas hypertension was associated with a lower risk of the primary outcomes. In patients with hypertension, factors associated with an increased risk of the primary outcomes were aging, male sex, severe renal impairment, and diabetes mellitus, but not ACEi/ARB, cerebro-cardiovascular diseases, or COPD. Conclusions: Independent factors for the primary outcomes were aging, male sex, COPD, severe renal impairment, and diabetes, but not ACEi/ARB, in the COVID-19 patients with preexisting hypertension, diabetes mellitus, chronic renal failure, cerebro-cardiovascular disease or COPD. Based on this registry data analysis, more detailed data collection and analysis is needed with the cooperation of multiple healthcare facilities." @default.
• W4315703349 created "2023-01-12" @default.
• W4315703349 creator A5001922359 @default.
• W4315703349 creator A5002303307 @default.
• W4315703349 creator A5014759209 @default.
• W4315703349 creator A5020090012 @default.
• W4315703349 creator A5057845283 @default.
• W4315703349 creator A5058761966 @default.
• W4315703349 creator A5067354013 @default.
• W4315703349 creator A5067747157 @default.
• W4315703349 creator A5069400219 @default.
• W4315703349 creator A5074167675 @default.
• W4315703349 date "2023-01-01" @default.
• W4315703349 modified "2023-10-02" @default.
• W4315703349 title "PS-BPC06-1: RENIN-ANGIOTENSIN SYSTEM BLOCKER AND THE COVID-19 AGGRAVATION: REPORT BY THE COVID-19 REGISTRY JAPAN" @default.
• W4315703349 doi "https://doi.org/10.1097/01.hjh.0000915856.82959.d1" @default.
• W4315703349 hasPublicationYear "2023" @default.
• W4315703349 type Work @default.
• W4315703349 citedByCount "0" @default.
• W4315703349 crossrefType "journal-article" @default.
• W4315703349 hasAuthorship W4315703349A5001922359 @default.
• W4315703349 hasAuthorship W4315703349A5002303307 @default.
• W4315703349 hasAuthorship W4315703349A5014759209 @default.
• W4315703349 hasAuthorship W4315703349A5020090012 @default.
• W4315703349 hasAuthorship W4315703349A5057845283 @default.
• W4315703349 hasAuthorship W4315703349A5058761966 @default.
• W4315703349 hasAuthorship W4315703349A5067354013 @default.
• W4315703349 hasAuthorship W4315703349A5067747157 @default.
• W4315703349 hasAuthorship W4315703349A5069400219 @default.
• W4315703349 hasAuthorship W4315703349A5074167675 @default.
• W4315703349 hasBestOaLocation W43157033491 @default.
• W4315703349 hasConcept C126322002 @default.
• W4315703349 hasConcept C134018914 @default.
• W4315703349 hasConcept C151730666 @default.
• W4315703349 hasConcept C177713679 @default.
• W4315703349 hasConcept C2776780178 @default.
• W4315703349 hasConcept C2778653478 @default.
• W4315703349 hasConcept C2779134260 @default.
• W4315703349 hasConcept C2779343474 @default.
• W4315703349 hasConcept C555293320 @default.
• W4315703349 hasConcept C71924100 @default.
• W4315703349 hasConcept C86803240 @default.
• W4315703349 hasConceptScore W4315703349C126322002 @default.
• W4315703349 hasConceptScore W4315703349C134018914 @default.
• W4315703349 hasConceptScore W4315703349C151730666 @default.
• W4315703349 hasConceptScore W4315703349C177713679 @default.
• W4315703349 hasConceptScore W4315703349C2776780178 @default.
• W4315703349 hasConceptScore W4315703349C2778653478 @default.
• W4315703349 hasConceptScore W4315703349C2779134260 @default.
• W4315703349 hasConceptScore W4315703349C2779343474 @default.
• W4315703349 hasConceptScore W4315703349C555293320 @default.
• W4315703349 hasConceptScore W4315703349C71924100 @default.
• W4315703349 hasConceptScore W4315703349C86803240 @default.
• W4315703349 hasIssue "Suppl 1" @default.
• W4315703349 hasLocation W43157033491 @default.
• W4315703349 hasLocation W43157033492 @default.
• W4315703349 hasOpenAccess W4315703349 @default.
• W4315703349 hasPrimaryLocation W43157033491 @default.
• W4315703349 hasRelatedWork W1563850031 @default.
• W4315703349 hasRelatedWork W1588968920 @default.
• W4315703349 hasRelatedWork W2168449172 @default.
• W4315703349 hasRelatedWork W2362299873 @default.
• W4315703349 hasRelatedWork W2372071230 @default.
• W4315703349 hasRelatedWork W2415759662 @default.
• W4315703349 hasRelatedWork W2471594942 @default.
• W4315703349 hasRelatedWork W2888428943 @default.
• W4315703349 hasRelatedWork W3036934084 @default.
• W4315703349 hasRelatedWork W4223429971 @default.
• W4315703349 hasVolume "41" @default.
• W4315703349 isParatext "false" @default.
• W4315703349 isRetracted "false" @default.
• W4315703349 workType "article" @default.